BRANFORD, Conn., Aug. 10, 2011 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM) today reported financial results for the second quarter of 2011, ended June 30, 2011. Worldwide FORE-SIGHT® Absolute Tissue Oximetry revenues increased to $1.8 million, or 30% over the second quarter of 2010.
